
2021-12-23 13:41:36
Industry News: Drug Development
FDA denies approval of TAK-721 (budesonide oral suspension) for EoE Takeda, the pharmaceutical company developing TAK-721 (budesonide oral sus ...
Find out More2022-05-21 13:38:14
2021-12-23 13:41:36
FDA denies approval of TAK-721 (budesonide oral suspension) for EoE Takeda, the pharmaceutical company developing TAK-721 (budesonide oral sus ...
Find out More2020-09-09 11:10:41
For Immediate Release ...
Find out More2020-03-08 21:01:00
The American Partnership for Eosinophilic Disorders (APFED) is closely monitoring developments regarding the novel coronavirus (COVID-19) outbreak and the poten ...
Find out More2019-10-31 17:00:09
This week, APFED was onsite at the American College of Gastroenterology’s 84th Annual Scientific Meeting and Postgraduate Course (ACG 2019) where attendees fr ...
Find out More